InteliSwab™ COVID-19 Rapid Antigen Test, For results anytime and anywhere OTC (Over the Counter) Version, 2 Tests/Box

FREE UPS GROUND SHIPPING WITH $50 PURCHASE

Meet InteliSwab™, the COVID-19 rapid antigen test that makes self-testing remarkably simple. It’s so user-friendly, it can be used anytime and anywhere, and requires less than one minute of hands-on time. InteliSwab has received FDA Emergency Use Authorization* for self-testing. You do not need to ship samples to a lab or get a prescription from your healthcare provider. This easy to use self-test requires just 3 key steps: Swab, Swirl and See your result in 30 minutes. There is no assembly required. InteliSwab makes testing so easy, you’ll know you did it right.

Emergency Use Authorization

• Over-the-counter use
• Prescription home use
• Point-of-care use

InteliSwab™ COVID-19 Rapid Antigen Test - Results Anytime and Anywhere

• Detects active COVID-19 infection for both symptomatic and asymptomatic use
• Shallow and gentle nasal swab (lower nostril)
• 98% of untrained, unproctored users found InteliSwab™ easy to use
• Requires less than one minute of hands-on time
• No lab needed and no assembly required 
• Get your results in 30 minutes
• No difficult or confusing steps
• No dropper bottle or number of drops required
• No batteries or instruments needed
• Designed in Bethlehem, Pennsylvania by OraSure Technologies, Inc.
• Suitable for ages 15 and up
• Bilingual instructions included in the test kit

Instructions "how the test works"

1. Swab: Collect sample from nostrils with gentle, soft swab embedded in test device
2. Swirl: Stir test device in tube
3. See: Read your results after 30 minutes
4. If negative, test again with 24-36 hours between tests

*This product has not been FDA cleared or approved; but has been authorized by FDA under an EUA; This product has been authorized only for the detection of proteins from SARS- CoV-2, not for any other viruses or pathogens; and, This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
 **For complete testing instructions and interpretation of results, refer to the Instructions for use.

We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here and believed to be accureate at the time of posting.

Download InteliSwab Covid-19 Antigen Documentation

FDA Letter of Authorization	Positive Result Reference Card
Instructions for Use (English)	Product Brochure
Instrucciones de uso (español)	Healthcare Provider Fact Sheet
Fact Sheet for Individuals	Healthcare Provider IFU